Protect your patients and employees with intelligent drug diversion monitoring
Imprivata Drug Diversion Intelligence (DDI) leverages AI and behavioral analytics to monitor the entire lifecycle of controlled substances. By analyzing user behavior and dispensing patterns, DDI helps healthcare organizations identify potential diversion incidents to ensure patient safety and regulatory compliance.
Understanding Drug Diversion Intelligence
Discover how Imprivata's DDI solution utilizes AI and user behavior analytics to monitor controlled substances, detect potential diversion, and enhance patient safety.
Key benefits of Imprivata Drug Diversion Intelligence
Accurately identify patients with touchless authentication workflows
Identify unresponsive patients or those unable to identify themselves
Retrieve digital health records with guided enrollment on a palm scanner
One solution for identification and matching with vendors such as Verato
Wide integration network of ADT, EHR, and EMPI systems
Keep the correct records with the patient throughout their care journey
DDI Overview Walkthrough
Take a look at DDI’s Dashboards, Reports, Alerts, Investigations and Governance tabs
Real stories. Real impact.
Security and Privacy Certifications
Frequently asked questions
Skip list contentWhat is drug diversion?
How can we adopt drug diversion monitoring without signaling distrust to our staff?
How does DDI handle the problem of inconsistent drug naming across disparate systems?
How does DDI support controlled substances lifecycle auditing?
Can DDI support e-prescribing security?
What is Patient Privacy Intelligence (PPI) and how does it relate to DDI?
